On Monday, Masimo received an upgrade to its Relative Strength (RS) Rating, from 70 to 78.
Can You Really Time The Stock Market?
This exclusive rating from Investor's Business Daily identifies price performance with a 1 (worst) to 99 (best) score. The grade shows how a stock's price behavior over the trailing 52 weeks compares to all the other stocks in our database.
History reveals that the stocks that go on to make the biggest gains often have an RS Rating north of 80 in the early stages of their moves. See if Masimo can continue to show renewed price strength and clear that threshold.
Masimo is trying to complete a consolidation with a 194.88 entry. See if it can clear the breakout price in volume at least 40% higher than normal.
In terms of top and bottom line numbers, the company has posted four quarters of increasing earnings growth. Sales growth has also moved higher during the same period.
Masimo earns the No. 4 rank among its peers in the Medical-Systems/Equipment industry group. iRadimed is the No. 1-ranked stock within the group.
This article was created automatically with Stats Perform's Wordsmith software using data and article templates supplied by Investor's Business Daily. An IBD journalist may have edited the article.
RELATED:
Which Stocks Are Showing Rising Relative Strength?
Why Should You Use IBD's Relative Strength Rating?
How Relative Strength Line Can Help You Judge A Stock
Ready To Grow Your Investing Skills? Join An IBD Meetup Group!
